Blueprint Medicines Corp

NASDAQ:BPMC   3:59:59 PM EDT
68.24
-2.85 (-4.01%)
4:00:05 PM EDT: $68.37 +0.13 (+0.19%)
Other Pre-Announcement

Blueprint Medicines Reports Q2 Loss Per Share $2.68

Published: 08/02/2022 11:41 GMT
Blueprint Medicines Corp (BPMC) - Blueprint Medicines Reports Second Quarter 2022 Results.
Q2 Loss per Share $2.68.
Q2 Revenue $36.5 Million.
Sees FY 2022 Revenue $180 Million to $200 Million.
Q2 Earnings per Share View $-2.23, Revenue View $37.2 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $194.9 Million -- Refinitiv Ibes Data (analyst estimates).